26.14
-0.42%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Kontour XiAn Medical Technology Co
Its shares trade on Shanghai under the ticker 688314.SS. It has been listed since 18 May 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥349.6m and net income of CN¥98.8m. At that date it held total assets of CN¥909.2m and shareholders' equity of CN¥717.8m.
Kontour XiAn Medical Technology Co Ltd is a CN-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Xi'An, Shaanxi. The company went IPO on 2021-05-18. Kontour XiAn Medical Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of Class-III implantable medical device products. The firm's main products include titanium skull repair and fixation products for neurosurgical implantation and poly-ether-ether-ketone (PEEK) skull repair and fixation products, as well as sternum fixation products, neurospine products, supporting implant tools and other products. The firm's main products are used in neurosurgery skull repair fixation and cardiothoracic surgery sternal fixation. The firm distributes its products both in the domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 18 May 2021
- Employees
- 311
- Website
- kontourmedical.com.cn ↗
Leadership
Pay as last reported
- Mr. Liren HuChairman of the Board, Acting Secretary of the Board, since 2022
- Ms. You WuChief Financial Officer, Deputy General Manager, Director, since 2022
- Ms. Weiwei ShangDeputy General Manager
- Ligong HuDirector
- Dong WuDirector
- Ruoyu ZhaoDirector
- Hailong ZhuDirector
- Yixin GuoIndependent Director
- Zengtao WangIndependent Director
- He ZhangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Company is a China-based firm with a focus on Class-III implantable medical devices.
- Operates in the Health Care Equipment & Supplies industry with specific product lines.
- Has both domestic and overseas market distribution for its products.
Weaknesses
- Company is a relatively new entrant with an IPO in 2021.
- Limited product range as it focuses on specific medical device categories.
- Relies on a single sector (Health Care) for its business operations.
Opportunities
- Expansion into new markets for Class-III medical devices.
- Growth potential in the neurosurgery and cardiothoracic surgery sectors.
- Potential for increased international distribution of products.
Threats
- Competition from established medical device manufacturers.
- Regulatory challenges in the medical device industry.
- Dependence on a single industry sector for revenue.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.